↓ Skip to main content

Development of stem cell-based therapy for Parkinson’s disease

Overview of attention for article published in Translational Neurodegeneration, September 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

blogs
1 blog
twitter
1 X user
facebook
1 Facebook page

Citations

dimensions_citation
53 Dimensions

Readers on

mendeley
103 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Development of stem cell-based therapy for Parkinson’s disease
Published in
Translational Neurodegeneration, September 2015
DOI 10.1186/s40035-015-0039-8
Pubmed ID
Authors

Fabin Han, Deborah Baremberg, Junyu Gao, Jing Duan, Xianjie Lu, Nan Zhang, Qingfa Chen

Abstract

Parkinson's disease (PD) is one of the most common neurodegenerative disorders of aging, characterized by the degeneration of dopamine neurons (DA neurons) in the substantial nigra, leading to the advent of both motor symptoms and non-motor symptoms. Current treatments include electrical stimulation of the affected brain areas and dopamine replacement therapy. Even though both categories are effective in treating PD patients, the disease progression cannot be stopped. The research advance into cell therapies provides exciting potential for the treatment of PD. Current cell sources include neural stem cells (NSCs) from fetal brain tissues, human embryonic stem cells (hESCs), induced pluripotent stem cells (iPSCs) and directly induced dopamine neurons (iDA neurons). Here, we evaluate the research progress in different cell sources with a focus on using iPSCs as a valuable source and propose key challenges for developing cells suitable for large-scale clinical applications in the treatment of PD.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 103 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
France 1 <1%
Switzerland 1 <1%
Unknown 100 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 32 31%
Student > Ph. D. Student 14 14%
Student > Master 12 12%
Student > Doctoral Student 9 9%
Student > Postgraduate 7 7%
Other 10 10%
Unknown 19 18%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 20 19%
Agricultural and Biological Sciences 19 18%
Neuroscience 14 14%
Medicine and Dentistry 11 11%
Engineering 6 6%
Other 11 11%
Unknown 22 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 September 2015.
All research outputs
#3,061,567
of 25,374,647 outputs
Outputs from Translational Neurodegeneration
#130
of 384 outputs
Outputs of similar age
#38,379
of 277,002 outputs
Outputs of similar age from Translational Neurodegeneration
#3
of 7 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 384 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.7. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 277,002 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 4 of them.